| P50 | author | Daniel H Solomon | Q91503755 |
| P2093 | author name string | Jun Liu | |
| | Seoyoung C Kim | |
| P2860 | cites work | Newly detected atrial fibrillation and compliance with antithrombotic guidelines | Q28218990 |
| | Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men | Q29619308 |
| | Relation of multiple inflammatory biomarkers to incident atrial fibrillation | Q33573035 |
| | Validation of rheumatoid arthritis diagnoses in health care utilization data | Q33827617 |
| | A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women | Q33992740 |
| | Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis | Q34182804 |
| | Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity | Q34238357 |
| | Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study | Q34727157 |
| | A combined comorbidity score predicted mortality in elderly patients better than existing scores | Q35000472 |
| | High-sensitivity C-reactive protein, statin therapy, and risks of atrial fibrillation: an exploratory analysis of the JUPITER trial | Q35756480 |
| | Risk of atrial fibrillation and stroke in rheumatoid arthritis: Danish nationwide cohort study | Q35815364 |
| | Inflammation in the genesis and perpetuation of atrial fibrillation | Q36173608 |
| | Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis | Q36791624 |
| | Moving beyond JUPITER: will inhibiting inflammation reduce vascular event rates? | Q37279687 |
| | Heart involvement in rheumatoid arthritis: systematic review and meta-analysis | Q38019111 |
| | Inflammation in atrial fibrillation | Q38063604 |
| | Inflammatory biomarkers as risk factors for future atrial fibrillation. An eleven-year follow-up of 6315 men and women: the Tromsø study | Q39539994 |
| | C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study | Q40828366 |
| | Glucocorticoid use and risk of atrial fibrillation or flutter: a population-based, case-control study | Q43721348 |
| | Analysis of pravastatin to prevent recurrence of atrial fibrillation after electrical cardioversion | Q44799248 |
| | Non-steroidal anti-inflammatory drug use and risk of atrial fibrillation or flutter: population based case-control study | Q45000274 |
| | Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation | Q46433523 |
| | The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study | Q72198409 |
| | Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects | Q73628316 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| | atrial fibrillation | Q815819 |
| P304 | page(s) | 1091-1095 | |
| P577 | publication date | 2013-04-20 | |
| P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
| P1476 | title | The risk of atrial fibrillation in patients with rheumatoid arthritis | |
| P478 | volume | 73 | |